Pharmaceuticals News

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – March 27, 2025Idorsia Ltd (SIX: IDIA) today announced the publication of the Annual Report 2024 – consisting of the Business...

«Ad hoc-Mitteilung gemäss Art. 53 KR»  Pratteln, Schweiz, 27. März 2025 - Santhera Pharmaceuticals (SIX: SANN) schlägt der kommenden Generalversammlung vom 20. Mai 2025 die Wahl von Dr. Melanie Rolli...

Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, March 27, 2025 – Santhera Pharmaceuticals (SIX: SANN) proposes to elect Dr. Melanie Rolli as an Independent Director at the upcoming...

Amaran Biotech, a next-generation Contract Development and Manufacturing Organization (CDMO), was honored with the "Best CDMO in Automated Aseptic Filling"

Junshi Biosciences' toripalimab (LOQTORZI®) was approved as the first and only approved immuno-oncology treatment for NPC in Singapore.

PALO ALTO, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and...

NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that Ryoncil®...

SAN FRANCISCO, March 26, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (Nasdaq: ME), a leading human genetics and biotechnology company, today announced that it has...

Heildartekjur á árinu 2024 voru 492 milljónir dollara, sem er 427% aukning frá fyrra áriSölutekjur á árinu 2023 voru 273 milljónir dollara, sem er 462% aukning frá fyrra áriAðlöguð EBITDA framlegð var...

Total Revenues in 2024 reached $492 million, representing a 427% increase over prior yearProduct Revenues in 2024 reached $273 million, representing a 462% increase over prior yearAdjusted EBITDA in...